Characterization of a new muscarinic receptor antagonist PNU-171990 in guinea pig, cat and human smooth muscle

被引:2
作者
Modiri, AR
Vasänge, M
Alberts, P
Jossan, SS
Sundquist, S
Gillberg, PG
机构
[1] Biovitrum, Dept Biol, SE-75137 Uppsala, Sweden
[2] Pharmacia, Dept Pharmacol, Uppsala, Sweden
[3] Apoteksbolaget, Jonkoping, Sweden
关键词
bladder; overactive; irritable bowel syndrome; urinary bladder; ileum;
D O I
10.1016/S0014-2999(02)02227-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present study was done to characterize a new compound, PNU-171990, 2-diisopropyl aminoethyl 1-phenylcyclopentane carboxylate hydrochloride, with functional smooth muscle selectivity at least as high as tolterodine. In vitro homogenates of guinea pig cerebral cortex, parotid gland, heart, urinary bladder, and Chinese hamster ovary (CHO) cells expressing human muscarinic m(1)-m(5) receptors PNU-171990 did not show selectivity for any subtype (pK(i), 7.72-8.64). PNU-171990 caused a parallel shift in the concentration-response curve for carbachol-induced contraction of smooth muscle from guinea pig bladder (pK(B), 7.65), guinea pig ileum (pK(B), 8.48), and human ileum (pK(B), 7.10). In vivo PNU-171990 inhibited urinary bladder contraction with a significantly lower ID50 than on the salivary secretion (206 and 706 nmol/kg, respectively, P<0.05). In conclusion, PNU-171990 is a competitive and potent muscarinic receptor antagonist in vitro with a numerically better selectivity ratio for the bladder contraction over salivation in vivo than tolterodine. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:171 / 175
页数:5
相关论文
共 14 条
[1]   Characterisation of the functional α-adrenoceptor subtype in the isolated female pig urethra [J].
Alberts, P ;
Bergström, PAC ;
Fredrickson, MG .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 371 (01) :31-38
[2]   THE EFFECTS OF ATROPINE ON (H-3)-LABELED ACETYLCHOLINE SECRETION FROM GUINEA-PIG MYENTERIC PLEXUS EVOKED ELECTRICALLY OR BY HIGH POTASSIUM [J].
ALBERTS, P ;
BARTFAI, T ;
STJARNE, L .
JOURNAL OF PHYSIOLOGY-LONDON, 1982, 329 (AUG) :93-112
[3]  
Caulfield MP, 1998, PHARMACOL REV, V50, P279
[4]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[5]   Functional gut disorders: From motility to sensitivity disorders. A review of current and investigational drugs for their management [J].
De Ponti, F ;
Malagelada, JR .
PHARMACOLOGY & THERAPEUTICS, 1998, 80 (01) :49-88
[6]   Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder [J].
Hegde, SS ;
Eglen, RM .
LIFE SCIENCES, 1999, 64 (6-7) :419-428
[7]   Functional role of M-2 and M-3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo [J].
Hegde, SS ;
Choppin, A ;
Bonhaus, D ;
Briaud, S ;
Loeb, M ;
Moy, TM ;
Loury, D ;
Eglen, RM .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 (08) :1409-1418
[8]  
KENAKIN T, 1997, PHARM ANAL DRUG RECE, P232
[9]   Tolterodine - A new bladder-selective antimuscarinic agent [J].
Nilvebrant, L ;
Andersson, KE ;
Gillberg, PG ;
Stahl, M ;
Sparf, B .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 327 (2-3) :195-207
[10]   Clinical experiences with tolterodine [J].
Nilvebrant, L .
LIFE SCIENCES, 2001, 68 (22-23) :2549-2556